How Does Eyemycin Work? Mechanism of Action Explained in Plain English

If you've been prescribed Eyemycin (erythromycin ophthalmic ointment), you might wonder: how exactly does a small ribbon of ointment clear up a bacterial eye infection? The answer comes down to the clever way erythromycin interrupts the bacterial growth process — without harming human cells.

The Short Answer: Eyemycin Starves Bacteria of the Proteins They Need to Grow

Erythromycin works by blocking bacteria from making the proteins they need to survive and multiply. Without these proteins, the bacteria cannot grow or reproduce. The immune system then clears out the weakened or dying bacteria, resolving the infection.

Understanding the Mechanism: Protein Synthesis Inhibition

Every living cell — including bacterial cells — needs to build proteins to function. Proteins are the workhorses of biology: they build cell walls, run chemical reactions, create energy, and keep the cell alive. Without proteins, a bacterium dies.

To make proteins, cells use structures called ribosomes — tiny molecular machines that read genetic instructions (from RNA) and assemble amino acids into protein chains. Bacterial ribosomes are different from human ribosomes in a key structural way: they are made up of two subunits called 30S and 50S (vs. the 40S and 60S subunits in human cells).

Erythromycin exploits this difference. It binds specifically to the bacterial 50S ribosomal subunit — the part responsible for a step called transpeptidation (chain elongation), where new amino acids are added to the growing protein chain. By blocking this step, erythromycin stops protein production mid-process. The bacteria can't complete their proteins, can't grow, and eventually die.

Because erythromycin targets the 50S ribosomal subunit that is unique to bacteria, human cells are not affected. This is why erythromycin treats the infection without damaging the eye tissues it's applied to.

Is Eyemycin Bacteriostatic or Bactericidal?

Erythromycin is primarily

bacteriostatic — meaning it stops bacteria from growing rather than directly killing them. The immune system then eliminates the non-multiplying bacteria. In high enough concentrations, erythromycin can also be bactericidal (directly killing bacteria) for some organisms.

This is important because it means erythromycin works best when the immune system is healthy and able to clear the arrested bacteria. It's also a

time-dependent antibiotic: it works best when maintained at a consistent concentration over time, which is why it's dosed multiple times per day.

Which Bacteria Does Erythromycin Target?

Erythromycin was originally produced from a strain of Streptomyces erythraeus bacteria in the 1950s. Its spectrum of activity includes:

Gram-positive bacteria: Streptococcus pyogenes, Staphylococcus aureus (including penicillinase-producing strains), alpha-hemolytic streptococci

Gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae (not all strains), Chlamydia trachomatis, Treponema pallidum, Corynebacterium diphtheriae

Why Is Erythromycin Resistance a Growing Problem?

Erythromycin has been used systemically (as oral pills) for decades to treat ear infections, respiratory infections, and STIs. This widespread systemic use has created significant selective pressure, and many bacteria — particularly Staphylococcus species — have developed resistance mechanisms that prevent erythromycin from binding to their ribosomes.

For eye infections specifically, some studies have found Staphylococcal resistance rates as high as 70% among ocular isolates. This is why many ophthalmologists have shifted to tobramycin, azithromycin, or fluoroquinolones for suspected staphylococcal infections — even before considering the shortage.

How Does Erythromycin Differ From Other Eye Antibiotics?

vs. Azithromycin (AzaSite): Also a macrolide, but broader spectrum, higher tissue penetration, longer half-life in tissue, and available as drops (no blurred vision from ointment)

vs. Tobramycin: Aminoglycoside — binds the 30S ribosomal subunit; broader gram-negative coverage including Pseudomonas; bactericidal

vs. Fluoroquinolones (ciprofloxacin, moxifloxacin): Different target entirely — fluoroquinolones block bacterial DNA replication enzymes (DNA gyrase, topoisomerase IV); concentration-dependent; bactericidal; very broad spectrum

vs. Bacitracin: Works differently — destroys bacterial cell walls; bactericidal; less systemic resistance pressure because bacitracin has no oral form

To learn about specific dosing and usage instructions, visit our guide What Is Eyemycin? Uses, Dosage, and What You Need to Know. If you're having trouble finding this medication at a pharmacy, medfinder can check nearby pharmacies for available stock.